Korean J Hematol 1995; 30(2):
Published online June 30, 1995
© The Korean Society of Hematology
최종원, 이희주, 서진태, 김정희, 김시영, 윤휘중, 조경삼, 김영일
경희대학교 의과대학 임상병리과학교실,
경희대학교 의과대학 내과학교실,
경희대학교 의과대학 면역학연구실
Background: Close association between t(14;18) chromosomal translocation and
lymphomagenesis has been reported in patients with non-Hodgkin lymphoma(NHL). The
t(14;18) causes bcl-2 oncogene to be fused with joining segment of immunoglobulin
gene(JH). The purpose of this study was to investigate the prevalence of bcl-2/JH gene
rearrangement in lymphoproliferative diseases involving bone marrow and its difference
according to the subtypes of NHL.
Methods: Authors examined the bone marrows of 45 patients with advanced-stage
NHL, 6 patients with chronic lymphocytic leukemia(CLL), 1 patient with
angioimmunoblastic lymphadenopathy DNAs were extracted from the stored bone
marrow slides and paraffin-embedded bone marrow biopsy specimens. Nested
polymerase chain reaction(PCR) technique was used for the amplification of bcl-2/JH
fusion gene.
Results: Of 45 NHL patients, 9 showed bcl-2/JH rearrangement by one step PCR
technique. Three additional cases were detected only by using nested PCR technique.
Seven out of 12 PCR positive cases showed 230bp amplification product and the rest
showed various PCR product size from 230bp to 720bp. One case revealed double
amplification bands of 180bp and 430bp simultaneously. The incidence of bcl-2/JH
rearrangement according to NHL subtype was high in diffuse large cell
lymphoma(37.5%).
Conclusion: Bcl-2 translocation is present in 26.7% of NHL involving bone marrow.
Nested PCR technique can increase the detection rate of bcl-2/JH rearrangement,
especially for the cases of diffuse large cell lymphoma. For minimal residual disease
detection of NHL, the bcl-2/JH gene can be used as a molecular marker in t(14;18)
positive patients. Finally, further study on minor cluster region(MCR) and variant cluster
region(VCR) of t(14;18) is required to evaluate the exact incidence of bcl-2/JH gene rearrangement.
Keywords Bcl-2 gene, Nested PCR, NHL, Bone marrow
Korean J Hematol 1995; 30(2): 289-302
Published online June 30, 1995
Copyright © The Korean Society of Hematology.
최종원, 이희주, 서진태, 김정희, 김시영, 윤휘중, 조경삼, 김영일
경희대학교 의과대학 임상병리과학교실,
경희대학교 의과대학 내과학교실,
경희대학교 의과대학 면역학연구실
Jong Weon Choi, Hee Joo Lee, Jin Tae Suh, Jeong Hee Kim, Si Young Kim, Hwi Joong Yoon, Kyung Sam Cho, Young Il Kim
Department of Clinical Pathology, Internal Medicine, Immunology Research Laboratory, Kyung Hee University College of Medicine, Seoul, Korea
Background: Close association between t(14;18) chromosomal translocation and
lymphomagenesis has been reported in patients with non-Hodgkin lymphoma(NHL). The
t(14;18) causes bcl-2 oncogene to be fused with joining segment of immunoglobulin
gene(JH). The purpose of this study was to investigate the prevalence of bcl-2/JH gene
rearrangement in lymphoproliferative diseases involving bone marrow and its difference
according to the subtypes of NHL.
Methods: Authors examined the bone marrows of 45 patients with advanced-stage
NHL, 6 patients with chronic lymphocytic leukemia(CLL), 1 patient with
angioimmunoblastic lymphadenopathy DNAs were extracted from the stored bone
marrow slides and paraffin-embedded bone marrow biopsy specimens. Nested
polymerase chain reaction(PCR) technique was used for the amplification of bcl-2/JH
fusion gene.
Results: Of 45 NHL patients, 9 showed bcl-2/JH rearrangement by one step PCR
technique. Three additional cases were detected only by using nested PCR technique.
Seven out of 12 PCR positive cases showed 230bp amplification product and the rest
showed various PCR product size from 230bp to 720bp. One case revealed double
amplification bands of 180bp and 430bp simultaneously. The incidence of bcl-2/JH
rearrangement according to NHL subtype was high in diffuse large cell
lymphoma(37.5%).
Conclusion: Bcl-2 translocation is present in 26.7% of NHL involving bone marrow.
Nested PCR technique can increase the detection rate of bcl-2/JH rearrangement,
especially for the cases of diffuse large cell lymphoma. For minimal residual disease
detection of NHL, the bcl-2/JH gene can be used as a molecular marker in t(14;18)
positive patients. Finally, further study on minor cluster region(MCR) and variant cluster
region(VCR) of t(14;18) is required to evaluate the exact incidence of bcl-2/JH gene rearrangement.
Keywords: Bcl-2 gene, Nested PCR, NHL, Bone marrow
Hye Won Lee and Ja Young Lee
Blood Res 2024; 59():Željka Tkalčić Švabek, Marina Josipović, Ivana Horvat, Renata Zadro, and Sanja Davidović-Mrsić
Blood Res 2018; 53(2): 152-159Hyun-Young Kim, Mi-Ae Jang, Hee-Jin Kim, Seok Jin Kim, Won Seog Kim, and Sun-Hee Kim
Blood Res 2017; 52(3): 193-199